High levels of serum CA15 ‐3 and residual invasive tumor size are associated with poor prognosis for breast cancer patients with non‐pathological complete response after neoadjuvant chemotherapy

Journal of Surgical Oncology, EarlyView.

Source: Journal of Surgical Oncology - June 24, 2018 Category: Cancer & Oncology Authors: Yukie FujimotoMD , Tomoko HiguchiMD , Arisa NishimukaiMD , Yoshimasa MiyagawaMD , Ayako KiraMD, PhD , Hiromi OzawaMD , Ayako BunMD , Michiko ImamuraMD, PhD , Yasuo MiyoshiMD, PhD Source Type: research